A groundbreaking study funded by the National Institutes of Health (NIH) has emerged, presenting compelling evidence that connects severe chronic traumatic encephalopathy (CTE) to an increased risk of dementia. CTE is a degenerative brain condition that affects individuals who have endured repeated head trauma over time. The diagnosis of CTE can only be confirmed posthumously through the examination of brain tissue. While this research successfully established a link between severe forms of CTE—specifically stages III and IV—and dementia risk, it found no significant association between milder forms of CTE (stages I and II) and alterations in thought processes, emotional well-being, or daily functioning.
The investigation, spearheaded by researchers from the Boston University CTE Center in collaboration with the U.S. Department of Veterans Affairs Boston Healthcare System, examined the brains of 614 donors who had a history of repetitive head impacts. Importantly, none of these individuals were diagnosed with Alzheimer's disease, Lewy body disease, or frontotemporal lobar degeneration, which are three prevalent neurodegenerative disorders known to cause dementia.
CTE is characterized by the accumulation of abnormal tau protein. In normal brains, tau plays a critical role in maintaining the stability and proper functioning of nerve cells. However, in CTE, tau protein forms small, brownish tangles that cluster around tiny blood vessels within the brain's grooves, and as the disease progresses, these tangles become more widespread.
Dr. Amy Bany Adams, acting director at NIH’s National Institute of Neurological Disorders and Stroke (NINDS), remarked, "By examining hundreds of brains and ruling out other common neurodegenerative diseases, the research team could isolate CTE and correlate it with symptoms observed during the subjects’ lifetimes."
The findings revealed that individuals suffering from stage IV CTE were 4.5 times more likely to have experienced dementia during their lives compared to those without CTE. Additionally, stage III CTE was likewise associated with an elevated risk of dementia. On the contrary, stages I and II did not show any correlation with dementia, cognitive decline, or a decrease in daily functioning. Notably, mood or behavior changes were not documented at any stage of CTE.
Dr. Richard Hodes, the director of NIH’s National Institute on Aging (NIA), which also supported this research, emphasized the significant implications for future dementia studies. "Understanding the specific brain changes that lead to cognitive decline is crucial," he stated. "This study demonstrates that only severe CTE has a distinct connection to dementia, which is a vital differentiation for researchers, healthcare practitioners, and families."
Moreover, the study suggests that mood or behavioral shifts typically linked to CTE might actually stem from other neurological impacts of repetitive head traumas or could be influenced by unrelated medical or environmental factors.
These new findings build on earlier NIH-funded research published this year, which indicated that young athletes experiencing repetitive head impacts may undergo early cellular changes, such as immune system activation, alterations in blood vessels, and loss of certain brain cells, long before any tau accumulation becomes apparent. However, it remains uncertain whether these initial brain changes result in any symptoms or contribute to the development of CTE later in life. Collectively, these studies offer a clearer understanding of how repeated head impacts can affect brain health over time.
This research was made possible through funding from NINDS and NIA, representing a long-term federal investment that allowed for the analysis of one of the largest cohorts of CTE ever assembled. For the first time, researchers were able to disentangle the specific impacts of CTE on brain function and overall disease.
This investigation received support from grants provided by NINDS (U54 NS115266) and NIA (R01NS122854 and R01NS139383).
/Public Release. The material sourced from the original authors or organizations may reflect a specific moment in time and has been edited for clarity, style, and length. Mirage.News does not endorse any institutional positions; all views, opinions, and conclusions expressed are solely those of the authors. Read the full article here: (https://www.miragenews.com/nih-study-clearly-ties-risk-of-dementia-to-1608630/).
